Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion

Veterinary Microbiology

Volumn 62, Issue 4, 1998, Pages 303-311

  Kukreja, A ^a   Walker, C ^b   Fitzmaurice, T ^a   Awan, A ^a   Love, D N ^c   Whalley, J M ^b   Field, H J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Abortion; Equine herpesvirus 1; gB; Mouse model

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BACULOVIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMSTER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; KIDNEY CELL; MOUSE; NONHUMAN; PROTECTION; RABBIT; SEPTIC ABORTION; SHORT SURVEY; VIRUS ISOLATION;

CRICETINAE; EQUIDAE; EQUINE HERPESVIRUS 1; HERPESVIRIDAE; HERPESVIRUS 1; MURINAE; ORYCTOLAGUS CUNICULUS; UNIDENTIFIED BACULOVIRUS;

EID: 19244368305     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00211-9     Document Type: Article

References (29)

1. Allen, G.P., Bryans, J.T., 1986. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. In: Pandey, R., (Ed.), Prog. Vet. Microbiol. Immunol. 2, pp. 78-144.
2. Awan A.R., Field H.J. Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus-1. Antimicrob. Agents Chemother. 37:1993;2478-2482.
3. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: A new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
4. Awan A.R., Gibson J.S., Field H.J. A murine model for studying EHV-1-induced abortion. Res. Vet. Sci. 51:1991;94-99.
5. Awan A.R., Baxi M., Field H.J. EHV-1-induced abortion in mice and its relationship to stage of gestation. Res. Vet. Sci. 59:1995;139-145.
6. Baxi M.K., Borchers K., Bartels T., Schellenbach A., Baxi S., Field H.J. Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. Virus Res. 40:1996;33-45.
7. Bryans, J.T., Allen, G.P., 1989. Herpesvirus disease of the horse. In: Wittman, G., (Ed.), Herpesvirus Disease of Cattle, Horse and Pig. Kluwer, Boston, pp. 176-229.
8. Bryans J.T., Swerczek T.W., Darlington R.W., Crowe M.W. Neonatal foal disease associated with perinatal infection by equine herpesvirus-1. J. Eq. Med. Surg. 1:1977;20-26.
9. Burki F., Rossmanith W., Nowotny N., Pallan C., Mostl K., Lussy H. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Quarterly. 12:1990;80-86.
10. Chesters P.M., Allsop R., Purewal A., Edington N. Detection of latency-associated transcripts of equine herpesvirus-1 in equine leukocytes but not in trigeminal ganglia. J. Virol. 71:1997;3437-3443.
11. Dixon R.J., Hartley W.J., Hutchins D.R., Lepherd E.E., Feilen C., Jones R.F., Love D.N., Sabine M., Wells A.L. Perinatal foal mortality associated with a herpesvirus. Aust. Vet. J. 54:1978;103-105.
12. Edington N., Bridges C.G., Huckle A. Experimental reactivation of equine herpesvirus-1 (EHV-1) following the administration of corticosteroids. Equine vet. J. 17:1985;369-372.
13. Edington N., Smyth B., Griffiths L. The role of endothelial cell infection in the endometrium, placenta and foetus of equine herpesvirus-1 (EHV-1) abortions. J. Comp. Pathol. 104:1991;379-387.
14. Gibson J.S., Slater J.D., Awan A.R., Field H.J. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals - Primary and secondary infections and reactivation. Arch. Virol. 123:1992;351-366.
15. Gilkerson J.R., Love D.N., Whalley J.M. A review of equine herpesvirus vaccines: From the traditional to the experimental. Aust. Equine Vet. 15:1997;27-32.
16. Guo P., Goebel S., Perkus M.E., Taylor J., Norton E., Allen G., Languet B., Desmettre P., Paoletti P. Coexpression by vaccinia virus recombinants of equine herpesvirus-1 glycoproteins gp13 and gp14 results in potentiated immunity. J. Virol. 64:1990;2399-2406.
17. Hartley W.J., Dixon R.J. An outbreak of foal perinatal mortality due to equine herpesvirus type 1: Pathological observations. Equine Vet. J. 11:1979;215-218.
18. Norrild, B., 1985. Humoral responses to herpes simplex infections. In: Roizman, B., (Ed.), The Herpesviruses, Plenum, New York, pp. 69-86.
19. Osterrieder N., Wagner R., Brandmuller C., Schmidt P., Wolf H., Kaaden O.R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500-510.
20. Packiarajah P., Walker, C., Gilkerson, J., Whalley, J.M., Love, D.N., 1998. Immune responses and protective efficacy of recombinant baculovirus expressed glycoproteins of equine herpesvirus-1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Vet. Microbiol., 61, 261-298.
21. Smith K.C., Whitwell K.E., Binns M.M., Dolby C.A., Hannant D., Mumford J.A. Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equine herpesvirus-1. Equine Vet. J. 24:1992;256-259.
22. Spear P.G. Entry of alphaherpesviruses into cells. Sem. Virol. 4:1993;167-180.
23. Stokes A., Allen G.P., Pullen L.A., Murray P.K. A hamster model of equine herpesvirus type 1 (EHV-1) infection: Passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J. Gen. Virol. 70:1989;1173-1183.
24. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus expressed equine herpesvirus type 1 glycoprotein D and glycoprotein H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
25. Tewari D., Nair S.V., Deungria M.C., Lawrence G.L., Hayden M., Love D.N., Field H.J., Whalley J.M. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Arch. Virol. 140:1995;789-797.
26. Walker, C., Perotti, V.M., Love, D.N., Whalley, J.M., 1998. Infection with equine herpesvirus 1 (EHV-1) strain HVS25A in pregnant mice. J. Comp. Pathol., in press.
27. Welch H.M., Bridges C.G., Lyon A.M., Griffiths L., Edington N. Latent equine herpesviruses-1 and 4 - Detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J. Gen. Virol. 73:1992;261-268.
28. Wellington J.E., Love D.N., Whalley J.M. Evidence for involvement of equine herpesvirus-1 glycoprotein B in cell-cell fusion. Arch. Virol. 141:1996;167-175.
29. Whalley J.M., Robertson G.R., Scott N.A., Hudson G.C., Bell C.W., Woodworth L.M. Identification and nucleotide sequence of a gene in equine herpesvirus-1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB. J. Gen. Virol. 70:1989;383-394.